Centiva Capital’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Centiva Capital’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-390,327	Closed	-$3.96M	–	1769
2022 Q3	$3.96M	Buy	390,327 +278,700	+250%	+$2.81M	0.07%	197
2022 Q2	$1.12M	Buy	111,627 +5,951	+6%	+$59.8K	0.03%	557
2022 Q1	$1.06M	Buy	+105,676	New	+$1.06M	0.02%	676

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Centiva Capital's ARCK Position: Q4 2022 in Review

Centiva Capital sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 390,327 shares — an estimated $3.96M sold.

Centiva Capital first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $3.96M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Centiva Capital reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Centiva Capital sold 390,327 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $3.96M.
Centiva Capital first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Centiva Capital's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $3.96M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.